Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

125.50 +1.40 (+1.12%)
Streaming Delayed Price Updated: 2:39 PM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
Apple is appealing to reverse a U.S. import ban on certain Apple Watches stemming from a patent dispute with Masimo Corporation, arguing the patented Masimo wearable was theoretical and challenging the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
From Masimo
Via Business Wire
Analyst Scoreboard: 5 Ratings For Masimo
Via Benzinga
Masimo Corp. (NASDAQ: MASI) Making Surprising Moves in Monday Session
Via Investor Brand Network
Masimo Breaks Out To Eight-Month High On Proposed Consumer Biz Separation
The company is considering a separation for its audio and consumer-facing businesses. 
Via Investor's Business Daily
Recap: Masimo Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
A Preview Of Masimo's Earnings
Via Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
Via Benzinga
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence
Politan Capital Management's Quentin Koffey prepares for a proxy battle, seeking additional Masimo Corporation board seats. With a 9% stake, Koffey aims to influence the $7.1 billion market value... 
Via Benzinga
Wall Street Set To Open Weak Lower As Tech Feels China Chill: Analyst Says Stay Bullish 'If And Until This Changes'
Major U.S. index futures edged lower on Monday, reflecting the cautious mood from last week’s close. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning. 
Via InvestorPlace
Politan Nominates Two Independent Candidates for Masimo Board
From Politan Capital Management
Via Business Wire
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. 
Via Benzinga
Topics Stocks
Exposures US Equities
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
From Masimo Corporation
Via Business Wire
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Masimo Named One of Fast Company’s Most Innovative Companies in North America
From Masimo
Via Business Wire
Apple Watch 2.0? New Patents Hint At Expansion Beyond Health Tracking After Masimo Fiasco
Apple has been considering incorporating anemometers, bolometers, heat flux sensors, solar radiation sensors, thermometers, and water sensors into future iterations of the Apple Watch. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
From Masimo
Via Business Wire
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
From Masimo Corporation
Via Business Wire
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
From Masimo Corporation
Via Business Wire
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
From Masimo
Via Business Wire
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
From Masimo
Via Business Wire
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
From Masimo
Via Business Wire
Tim Cook Opens Up On Apple Watch Ban, Licensing Masimo' Tech: 'We're Focused On Appeal'
Apple CEO Tim Cook has confirmed the company's plan to appeal the ban on its Apple Watch imposed in a patent dispute with Masimo, stating they have no intention of settling and will focus on the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
What Wall Street Experts Are Saying About Apple Ahead Of Earnings
Bulls and bears divided on Apple ahead of 'likely not great' report. 
Via Talk Markets
Vision Pro Exceeds Expectations, Banned Apple Watch Feature Saves Teen And More: Top News In Appleverse This Week
From booking a majority of TSMC's initial 2nm chips capacity to rolling out an "Alternative App Store" model in the EU, Apple's moves were far-reaching. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.